R&D

Centre for Genomic Regulation teams up with Almirall to develop new preclinical models for non-melanoma skin cancer

Global biopharmaceutical company Almirall has entered into a research collaboration with the Centre for Genomic Regulation (CRG), an international biomedical research institute of excellence. The partnership aims to develop...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Beckman Coulter unveils next generation immunoassay analyzer enabling elite laboratory performance with no daily maintenance

Beckman Coulter, a clinical diagnostics leader, today unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000...

Shift to consumer-first mindset is highest priority for digital pharma products going into 2023

The new report from Graphite Digital – Overcoming Contradictions – reveals that moving to a consumer-first mindset when it comes to digital products is...

Peli BioThermal launches Crēdo™ Go cold chain shipping solution

Peli BioThermal, the life science industry’s partner from discovery to distribution, announces its newest reusable, flexible temperature controlled shipping solution. Crēdo™ Go is designed...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

FDA moves forward with mail-back envelopes for opioid analgesics

The U.S. Food and Drug Administration is requiring manufacturers of opioid analgesics dispensed in outpatient settings to make prepaid mail-back envelopes available to outpatient...

Sustainability takes centre stage for Tower Cold Chain at LogiPharma

Temperature-controlled specialist Tower is returning to LogiPharma in 2023 to showcase how pharmaceutical manufacturers are using its passive containers to improve their logistics infrastructure,...

86% of pharma and biotech companies plan to invest in ‘digitally agile’ supply chains in next 12 months

86% of pharma and biotech companies say they plan to become more digitally agile, according to a new survey of 100 senior pharmaceutical executives. The...

ADVANZ PHARMA enters into exclusive agreement with Alvotech to commercialise a proposed biosimilar to Xolair

ADVANZ PHARMA has entered into an exclusive agreement with Alvotech for the exclusive license and supply rights for a proposed biosimilar to Xolair (omalizumab). Alvotech...

Approvals

Y-mAbs’ DANYELZA approved in Brazil for the treatment of high-risk neuroblastoma

The Brazilian Health Regulatory Agency, Agência Nacional de Vigilância Sanitária (Anvisa) has granted marketing authorization for Y-mAbs Therapeutics' DANYELZA (naxitamab-gqgk) 40mg/10mL injection. DANYELZA will...

Innoviva Specialty Therapeutics receives FDA approval for pneumonia treatment XACDURO

The U.S. Food and Drug Administration (FDA) has approved Innoviva Specialty Therapeutics' XACDURO (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use in...

Braeburn’s BRIXADI extended-release injection receives FDA approval for opioid use disorder

Akebia receives UK MHRA approval for Vafseo for symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis

U.S. FDA approves Indivior’s nasal spray for opioid overdose rescue

FDA approves Bausch + Lomb and Novaliq’s MIEBO to treat signs and symptoms of dry eye disease

Manufacturiung

Finance

Research & Development
Latest

R&D

Centre for Genomic Regulation teams up with Almirall to develop new preclinical models for non-melanoma skin cancer

Global biopharmaceutical company Almirall has entered into a research collaboration with the Centre for Genomic Regulation (CRG), an international biomedical research institute of excellence....
R&D

CohBar and Morphogenesis enter into definitive merger agreement to advance an innovative late-stage clinical immuno-oncology pipeline of therapies to overcome resistance to cancer immunotherapy

CohBar and Morphogenesis have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage...
R&D

Centessa Pharmaceuticals receives Fast Track designation from the U.S. FDA for SerpinPC for hemophilia B

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Centessa Pharmaceuticals' SerpinPC, an investigational novel inhibitor of activated protein C...
R&D

UK makes £39m cash injection into AMR research

Cutting-edge research initiatives to develop new treatments to tackle antimicrobial resistance (AMR) will receive a cash injection of up to £39 million from the...
R&D

Lumen Bioscience receives U.S. FDA Fast Track Designation for LMN-201 to treat and prevent C. difficile infection

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for Lumen Bioscience's LMN-201, an investigational, orally delivered biologic drug to treat...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks